If approved, it would be the first needle-free insulin option for pediatric patients in 100+ years of insulin therapysBLA ...
The FDA has accepted MannKind's supplemental biologics license application (sBLA) for Afrezza (insulin human inhalation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results